Saturday, February 25, 2017

Cilostazol Fails to Best Aspirin for Post-Stroke Secondary Prevention (CME/CE)

(MedPage Today) -- Non-inferior overall but MI rates higher with PDE3 inhibitor
via Cilostazol Fails to Best Aspirin for Post-Stroke Secondary Prevention (CME/CE)
by

No comments:

Post a Comment